Krishana Phoschem Limited

NSE:KRISHANA.NS

209.43 (INR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 3,005.6392,807.5882,634.0112,302.372,648.971,653.6261,453.033465.106648.292661.745-286.5511,070.426781.677528.644127.732443.745509.336408.241246.107463.799426.476493.092356.195405.108340.377382.899
Cost of Revenue 2,083.892,011.4951,637.3721,852.3471,799.9841,026.5511,095.849216.774347.493421.597800.089724.067429.07253.796432.758216.99286.147231.321294.388251.58241.547257.979402.395210.172125.163178.887
Gross Profit 921.749796.093996.639450.023848.986627.075357.184248.332300.799240.148-1,086.64346.359352.607274.848-305.026226.755223.189176.92-48.281212.219184.929235.113-46.2194.936215.214204.012
Gross Profit Ratio 0.3070.2840.3780.1950.320.3790.2460.5340.4640.3633.7920.3240.4510.52-2.3880.5110.4380.433-0.1960.4580.4340.477-0.130.4810.6320.533
Reseach & Development Expenses 00000000000000000000000000
General & Administrative Expenses 000000129.23900021.524000115.33800073.29200066.009000
Selling & Marketing Expenses 0000000.7640000.4440000.1880000.5090000.325000
SG&A 462.718456.22744.849302.963303.61751.25130.003129.37116.655117.96221.968173.171234.964127.32115.52624.71721.30418.41773.8016.0996.09923.97166.3344.6424.5194.156
Other Expenses 08.5615.8882.677-8.729.60911.4855.4711.85210.088-10.3824.0223.73.27511.1012.4835.5560.566-85.390.838-0.2320.521-0.1340.1260.0620
Operating Expenses 462.718456.227823.671302.963460.208387.024193.405184.078169.249171-1,263.073232.886284.52178.151-366.699132.405137.59131.528-85.39135.622133.16167.345-66.07137.518129.633126.916
Operating Income 323.205339.866178.856147.06380.058240.051175.26469.725133.40269.148176.086113.47368.08796.69761.67394.3585.59945.39237.10976.59751.76967.76819.8757.41885.58176.976
Operating Income Ratio 0.1080.1210.0680.0640.1430.1450.1210.150.2060.104-0.6150.1060.0870.1830.4830.2130.1680.1110.1510.1650.1210.1370.0560.1420.2510.201
Total Other Income Expenses Net -75.279-113.035-89.166-84.393-105.7-62.352-28.39-8.018-13.5783.941-15.954-4.353-3.454-2.7555.038-2.185-3.99-1.894-8.446-2.548-5.202-6.894-4.75-11.754-8.836-7.302
Income Before Tax 247.926226.83167.24962.667283.078177.699142.08956.236117.97273.089160.132109.1264.63393.94266.71192.16581.60943.49828.66371.72444.24160.87415.1245.66476.74569.674
Income Before Tax Ratio 0.0820.0810.0260.0270.1070.1070.0980.1210.1820.11-0.5590.1020.0830.1780.5220.2080.160.1070.1160.1550.1040.1230.0420.1130.2250.182
Income Tax Expense 80.48162.72311.67525.63490.06758.88879.7899.87920.25112.10752.12930.22621.76329.07618.64129.06725.76814.67223.0412.01714.80520.2217.26115.94718.19316.393
Net Income 167.445164.10855.57437.033193.011118.81162.346.35797.72160.982108.00378.89442.8764.81648.0763.09855.84128.8265.62357.65927.1140.6537.8629.71758.55253.281
Net Income Ratio 0.0560.0580.0210.0160.0730.0720.0430.10.1510.092-0.3770.0740.0550.1230.3760.1420.110.0710.0230.1240.0640.0820.0220.0730.1720.139
EPS 2.712.650.90.63.121.921.010.753.162.043.662.951.62.441.932.532.241.160.232.321.091.630.321.192.351.07
EPS Diluted 2.712.650.90.63.121.921.010.753.162.043.642.881.562.431.932.32.041.050.232.241.091.630.321.192.351.07
EBITDA 426.618427.313246.9238.558464.223333.672198.45890.978154.616100.384202.13129.44797.473126.43990.478125.524119.15373.98969.093104.47379.95496.41148.66883.34110.74596.862
EBITDA Ratio 0.1420.1490.10.1020.1750.2020.1370.1960.2380.152-0.650.1340.1250.2390.6830.2830.2340.1810.2910.2250.1870.1960.1370.2060.3250.253